Conversion of isoflavone glucosides to aglycones in soymilk by fermentation with lactic acid bacteria.

Conversion of isoflavone glucosides to aglycones in soymilk by fermentation with lactic acid bacteria. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Conversion of isoflavone glucosides to aglycones in soymilk by fermentation with lactic acid bacteria. Abstract Text:

Jiyeon Chun,Gyoung Min Kim,Kang Wook Lee,In Duck Choi,Gun-Hee Kwon,Jae-Young Park,Seon-Ju Jeong,Jeong-Sang Kim,Jeong Hwan Kim,Jiyeon Chun,Gyoung Min Kim,Kang Wook Lee,In Duck Choi,Gun-Hee Kwon,Jae-Young Park,Seon-Ju Jeong,Jeong-Sang Kim,Jeong Hwan Kim,

Four lactic acid bacteria (LAB), Lactobacillus paraplantarum KM, Enterococcus durans KH, Streptococcus salivarius HM and Weissella confusa JY, were isolated from humans and tested for their capabilities of converting isoflavone glucosides to aglycones in soymilk. Changes in growth, pH, and titratable acidity (TA) were investigated during fermentation at 37 degrees C for 12 h. After 6 to 9 h of fermentation, each population of 4 LAB reached 10(8) to 10(9) CFU/mL. The initial pH of 6.3 +/- 0.1 decreased while the TA of 0.13%+/- 0.01% increased as fermentation proceeded, resulting in the final range between 4.1 +/- 0.2 and 4.6 +/- 0.1 for pH and between 0.51%+/- 0.02% and 0.67%+/- 0.06% for TA after the 12 h of fermentation. The glucoside concentrations were significantly decreased in soymilks fermented with either L. paraplantarum KM, S. salivarius HM, or W. confusa JY with fermentation time (P < 0.05). L. paraplantarum KM was the best in percent conversion of glucosides to corresponding aglycones, resulting in 100%, 90%, and 61% hydrolysis of genistin, daidzin, and glycitin, respectively, in 6 h. Consequently, the aglycone concentrations in soymilk fermented with L. paraplantarum KM were 6 and 7-fold higher than the initial levels of daidzein and genistein, respectively, after 6 h of fermentation. Changes in the daidzin and genistin levels were not significant in soymilk fermented with E. durans KH. The rates of hydrolysis of glucosides varied depending on the species of LAB. Especially, L. paraplantarum KM seems to be a promising starter for bioactive-fermented soymilk based on its growth, acid production, and isoflavone conversion within a short time.

Conversion of isoflavone glucosides to aglycones in soymilk by fermentation with lactic acid bacteria. Publishing Authors By Initials

J Chun,GM Kim,KW Lee,ID Choi,GH Kwon,JY Park,SJ Jeong,JS Kim,JH Kim,J Chun,GM Kim,KW Lee,ID Choi,GH Kwon,JY Park,SJ Jeong,JS Kim,JH Kim,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Conversion of isoflavone glucosides to aglycones in soymilk by fermentation with lactic acid bacteria. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Journal of food science

VOLUME: 72

Page Numbers: M39-44

Journal Abbreviation:

ISSN: 1750-3841

DAY: 12

MONTH: Mar

YEAR: 2007

Conversion of isoflavone glucosides to aglycones in soymilk by fermentation with lactic acid bacteria. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 14052

Conversion of isoflavone glucosides to aglycones in soymilk by fermentation with lactic acid bacteria. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Conversion of isoflavone glucosides to aglycones in soymilk by fermentation with lactic acid bacteria. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Conversion of isoflavone glucosides to aglycones in soymilk by fermentation with lactic acid bacteria.

AFFILIATION: Div. of Applied Life Science, Graduate School, Inst. of Agriculture and Life Science, Gyeongsang National Univ., Jinju 660-701, Korea. jeonghkm@nongae.gsnu.ac.kr

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Food Sci

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Conversion of isoflavone glucosides to aglycones in soymilk by fermentation with lactic acid bacteria Related Publications

• Aberrant expression of MUC3 and MUC4 membrane-associated mucins and sialyl Le(x) antigen in pancreatic intraepithelial neoplasia.
• Aberrant expression of MUC5AC and MUC6 gastric mucins and sialyl Tn antigen in intraepithelial neoplasms of the pancreas.
• Advanced capabilities for future light sources.
• Aging of the population and the subsequent increase in the mistreatment of the elderly in Korea.
• Alkali-catalyzed beta-elimination of periodate-oxidized glycans: a novel method of chemical deglycosylation of mucin gene products in paraffin embedded sections.
• Altered mucin core peptide immunoreactivity in the colon polyp-carcinoma sequence.
• Basic fibroblast growth factor-induced translocation of p21-activated kinase to the membrane is independent of phospholipase C-gamma1 in the differentiation of PC12 cells.
• Biological properties and expression of mucins in 5-fluorouracil resistant HT29 human colon cancer cells.
• Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles.
• Chromosomal clustering of muscle-expressed genes in Caenorhabditis elegans.
• Drynariae Rhizoma promotes osteoblast differentiation and mineralization in MC3T3-E1 cells through regulation of bone morphogenetic protein-2, alkaline phosphatase, type I collagen and collagenase-1.
• Elderly Women's Grief in Korea.
• Expression of MUC2, MUC5AC and MUC6 apomucins in carcinoma, dysplasia and non-dysplastic epithelia of the gallbladder.
• Goblet cell-specific expression mediated by the MUC2 mucin gene promoter in the intestine of transgenic mice.
• Identification and characterization of the MUC2 (human intestinal mucin) gene 5'-flanking region: promoter activity in cultured cells.
• Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma.
• Induction of mucin gene expression in middle ear of rats by tumor necrosis factor-alpha: potential cause for mucoid otitis media.
• Initiation of transcription of the MUC3A human intestinal mucin from a TATA-less promoter and comparison with the MUC3B amino terminus.
• MUC3 human intestinal mucin. Analysis of gene structure, the carboxyl terminus, and a novel upstream repetitive region.
• Methylation status of promoters and expression of MUC2 and MUC5AC mucins in pancreatic cancer cells.
• Molecular cloning of human intestinal mucin (MUC2) cDNA. Identification of the amino terminus and overall sequence similarity to prepro-von Willebrand factor.
• Monoclonal antibodies against partially deglycosylated colon cancer mucin that recognize Tn antigen.
• Mouse intestinal goblet cells expressing SV40 T antigen directed by the MUC2 mucin gene promoter undergo apoptosis upon migration to the villi.
• Optical design of the U7 undulator beamline at the Pohang Light Source.
• Phorbol 12-myristate 13-acetate induces alteration in mucin gene expression and biological properties of colon cancer cells.
• Phorbol 12-myristate 13-acetate up-regulates the transcription of MUC2 intestinal mucin via Ras, ERK, and NF-kappa B.
• Stent-graft placement in a traumatic internal carotid-internal jugular fistula and pseudoaneurysm.
• Stereotactic aspiration of intracerebral haematoma: significance of surgical timing and haematoma volume reduction.
• Study of the aging perception.
• The Shank family of postsynaptic density proteins interacts with and promotes synaptic accumulation of the beta PIX guanine nucleotide exchange factor for Rac1 and Cdc42.